ToMore Vision
To More Vision is a cancertech company that leverages advanced AI technology and comprehensive genomics data to redefine cancer prognosis and treatment planning. Their multi-modal platform offers healthcare professionals enhanced accuracy and efficiency in cancer treatment, focusing on personalized medicine. By utilizing real-time tumor modeling and smart genetics correlation mapping, they aim to improve patient outcomes and revolutionize cancer care. The company is positioned at the forefront of precision oncology, providing innovative solutions that transcend traditional prognosis methods.
ToMore Vision
To More Vision is a cancertech company that leverages advanced AI technology and comprehensive genomics data to redefine cancer prognosis and treatment planning. Their multi-modal platform offers healthcare professionals enhanced accuracy and efficiency in cancer treatment, focusing on personalized medicine. By utilizing real-time tumor modeling and smart genetics correlation mapping, they aim to improve patient outcomes and revolutionize cancer care. The company is positioned at the forefront of precision oncology, providing innovative solutions that transcend traditional prognosis methods.
TL;DR
Company: ToMore Vision — AI-driven cancertech startup (London)
Founded: 2023
Focus: AI-powered oncology prognosis and multimodal tumor modelling
Stage / Size: Early-stage; headcount listed as 1–10
Company Overview
Problem Domain
Precision oncology — improving prognosis, diagnostic accuracy, and treatment planning for cancer patients using AI and genomics.
Founded
2023
Industry
Biotechnology